Clarity's Diagnosis and Treatment Guidance

Covering over 370 clinical topics for use in

primary care, Clarity’s Diagnosis and Treatment Guidance supports confident decision-making at the point of care.  

Referenced and linked to source evidence and covering over 1,200 clinical presentations or patient scenarios, this guidance helps healthcare professionals: 

  • Reach a diagnosis
  • Prescribe safely
  • Offer safe and effective treatment options or referral for specialist care
  • Create local protocols and guidance 

This new resource will be available only to customers outside of the UK from January 2021. To be notified of the launch, please fill in the form opposite.  

If you would like sample Asthma contentplease let us know by checking the box, and we will be in contact with details.

We collect and process data in accordance with our Privacy Policy

Practical clinical guidance for common conditions and symptoms

Sign up to be notified when Clarity's Diagnosis and Treatment Guidance is available on subscription.

© The Royal Pharmaceutical Society 2020. All Rights Reserved.  

RPS is a company incorporated in England Under Royal Charter. Company Number RC000799. 66-68 East Smithfield, London, E1W 1AW, UK